Y. Yamatsu

发表

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Y. Orba, H. Sawa, M. Sasaki, 2022, Journal of medicinal chemistry.

Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Y. Orba, H. Sawa, M. Sasaki, 2022, bioRxiv.